or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Public Statements

DeLauro On GlaxoSmithKline Fraud Settlement

Press Release

Location: Washington, DC

Congresswoman Rosa L. DeLauro (CT-3), Ranking Member on the Labor, Health, and Human Services Appropriations Subcommittee, issued the following statement in response to the Department of Justice's announcement that GlaxoSmithKline agreed to plead guilty and to pay $3 billion to resolve allegations of fraud and withholding of safety data about the controversial diabetes drug Avandia from the Food and Drug Administration (FDA). This is the largest health care fraud settlement in U.S. history.

"It is critical that American patients have access to safe and effective drugs, and also that they and their healthcare providers have accurate information about how risky those drugs are. It is simply unconscionable that lives were placed at risk because a private company withheld drug safety data from the FDA and healthcare professionals. Today's settlement is a step forward, and we must do more to prevent this from happening again."

Congresswoman DeLauro repeatedly called for an independent review of Avandia because of concerns about data integrity and drug safety. Independent studies have linked the drug to an increased risk of cardiovascular complications.

Back to top